Skip to main content
High RiskFDAfda-F-0012-2021UNDECLARED ALLERGEN

"Nettle Meadow Artisan Cheese *** Truffle Fromage Frais***Contains pasteurized goat and cows milk*** 5 oz."

Category
Units Affected
16
Recall Date
July 29, 2020
Issuing Agency
Hazard
Undeclared Allergen

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0012-2021.

Routine NY Agriculture and Markets inspection found pasteurization temperature was not recorded for two lots of cheese due to pasteurizer recorder chart malfunction.

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0012-2021.

Recall terminated by FDA.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact Lumazu, Llc Dba Nettle Meadow or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0012-2021.

LuMaZu, LLC dba Nettle Meadow

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

Lumazu, Llc Dba Nettle Meadow Recall FAQ

Lumazu, Llc Dba Nettle Meadow is the subject of a dairy safety report: "Nettle Meadow Artisan Cheese *** Truffle Fromage Frais***Contains pasteurized goat and cows milk*** 5 oz.". The notice was published on July 29, 2020 by the U.S. Food and Drug Administration (FDA). Approximately 16 units are potentially affected.